Financial Services / Capital MarketsNYSE
$69.82
-0.33 (-0.47%)
Book/ROE base 3Y
n/d
n/d CAGR · P/B n/d
Book/ROE base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
Book/ROE escenarios
weak_data · book/share n/d · quality 48.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$10.7B
P/E
13.6x
↑EV/EBITDA
N/A
•ROE
11.4%
↑Gross Margin
N/A
•Debt/Equity
0.26
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2025 · 17 años de histórico normalizado
Revenue CAGR
+11.3%
FCF CAGR
—
FCF margin
19.3%
FCF / Net income
1.54x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.46B · net income $683.8M · FCF $1.05B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | $5.46B | $5.46B | $4.91B | $4.29B | $4.33B | $3.62B | $2.68B | $2.35B | $2.19B | $3.00B | $2.64B | $2.38B | $2.25B | $2.02B | $1.63B | $1.42B | $1.40B | $1.10B | $888.8M |
| Net Income | $683.8M | $683.8M | $731.4M | $522.5M | $662.2M | $824.9M | $503.5M | $448.4M | $394.0M | $182.9M | $81.5M | $92.3M | $176.1M | $162.0M | $138.6M | $84.1M | $1.9M | $75.8M | $55.5M |
| EPS | 3.91 | 3.91 | 4.17 | 2.85 | 3.55 | 4.44 | 2.77 | 2.44 | 2.10 | 0.95 | 0.44 | 0.52 | 1.03 | 0.98 | 0.98 | 0.60 | 0.01 | 0.69 | 0.59 |
| Net Margin | 12.5% | 12.5% | 14.9% | 12.2% | 15.3% | 22.8% | 18.8% | 19.1% | 18.0% | 6.1% | 3.1% | 3.9% | 7.8% | 8.0% | 8.5% | 5.9% | 0.1% | 6.9% | 6.2% |
| Balance Sheet | |||||||||||||||||||
| Debt/Equity | 0.26 | 0.26 | 0.27 | 0.38 | 0.22 | — | 0.26 | 0.28 | 0.32 | 0.35 | 0.29 | 0.30 | 0.27 | 0.16 | 0.26 | — | — | — | — |
| Current Ratio | 0.88 | 0.88 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||
| Free Cash Flow | $1.05B | $1.05B | $416.6M | $447.4M | $1.08B | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Returns | |||||||||||||||||||
| ROE | 11.4% | 11.4% | 12.9% | 9.9% | 12.4% | — | 11.9% | 12.4% | 12.4% | 6.4% | 3.0% | 3.7% | 7.6% | 7.9% | 9.3% | 6.5% | 0.2% | 8.7% | 9.4% |
| Valuation | |||||||||||||||||||
| P/E | 13.61 | 13.61 | 17.31 | 16.39 | 11.30 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.93 | 1.93 | 2.11 | 1.50 | 1.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | |||||||||||||||||||
| Revenue Growth | 11.3% | 11.3% | 14.4% | -1.0% | — | 35.0% | 13.9% | 7.5% | -27.0% | 13.4% | 11.2% | 5.7% | 11.4% | 24.1% | 14.7% | 1.7% | 26.5% | 24.1% | — |
| EPS Growth | -6.1% | -6.1% | 46.0% | -19.5% | — | 60.1% | 13.7% | 16.2% | 120.8% | 114.0% | -15.3% | -48.9% | 5.0% | 0.0% | 64.2% | 4366.7% | -98.1% | 18.2% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
16.5%
EPS terminal req.
$6.20
Spread vs growth
-22.6%
5Y implied EPS CAGR
13.9%
EPS terminal req.
$7.50
Spread vs growth
-20.0%
10Y implied EPS CAGR
11.9%
EPS terminal req.
$12.07
Spread vs growth
-18.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+13.0%
Start / end P/E
15.1x → 17.8x
EPS bridge
4.17 → 3.91
Residual
-1.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.